SLFN12 and lung adenocarcinoma: Our analysis using the publicly available km-plotter tool [14] of gene expression profiles in a cohort of patients with non-small cell lung cancer showed that higher SLFN12 expression correlated with better survival in patients with lung adenocarcinoma (hazard ratio = 0.59, n = 719, p-value < 0.0001).